We experiment. Learn. Adapt. Stay ahead.
Then bring that knowledge to our clients.
Read: How we crowdfunded £2million
We built a global movement that crowdfunded £2million for a cancer busting virus & pioneered a new model to fundraise for medical research.
£2 million crowdfunded
International Media coverage:
Telegraph, Guardian, Mashable, FT, BBC 4 Today, The Times, Nature, TEDMED
Recognised as a pioneering a new way to fund medical research
We wanted to test if crowdfunding was viable and to develop key techniques for building a crowdfunding campaign. In particular this campaign would involve building an audience base quickly from scratch and challenging the traditional way that scientific research is funded. From research projects into advocacy, campaigning and storytelling with communities in Africa to collaborating with Universities or corporate partners to test the latest technology, we're always conducting Fieldcraft Studios Test Lab projects. We then bring that knowledge and experience to our clients.
For iCancer we joined forces with author Alexander Masters and Dominic Nutt, media consultant and neuroendocrine patient (NET), to launch a crowdfunding campaign to raise £2million for a potential cancer therapy. The cancer-busting virus, which if successfully developed could significantly extend the lives of NET (Neuroendocrine Tumor) patients, the same cancer that killed Steve Jobs. The treatment, developed by Uppsala University, was sitting in a freezer untested for lack of just £2million.
Fieldcraft Studios create campaigns that build a symbiotic relationship between social media and traditional media with each working as a force multiplier. We developed and produced the iCancer campaign strategy, content and media plan.
The crowdfunding campaign launched on the first anniversary of Steve Jobs passing and the donations immediately started flooding in.From a standing start we quickly brought together a global community of people who, informed and empowered by our campaign narrative, recognised their collective ability to bypass global pharma and fund medical treatments - the icancer treatment - themselves.
We achieved significant national and international coverage including Radio 4 Today, Financial Times, Telegraph, The Guardian and Mashable and Nature Magazine among many others. The project was also featured at a TEDMED conference. We also received huge celebrity support on Twitter. Most interesting was the rich and vocal debate we sparked in the cancer research community with our new approach to funding research. We announced we had reached our £2 million goal in the Telegraph on June 15th 2013, eight months after the campaign launch.